Related Experiment Video
Updated: Sep 1, 2025
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Prosthetic Replacement of the Ocular Surface Ecosystem for Terrien Marginal Degeneration: A Case Series
Bryan M Wong1, Tanya Trinh, Anubhav Garg
1Faculty of Medicine (B.M.W, A.G.), University of Toronto, Toronto, ON, Canada; Department of Ophthalmology and Vision Sciences (T.T., M.M., S.R., M.C., A.R.S., C.C.C.), University of Toronto, Toronto, ON, Canada; Sydney Eye Hospital (T.T.), Sydney, Australia; Kensington Eye Institute (S.R., M.C., A.R.S., C.C.C.), Toronto, ON, Canada; and New England College of Optometry (J.L.), Boston, MA.
Objectives:
To assess outcomes of the Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) treatment in patients with advanced Terrien marginal degeneration (TMD).
Methods:
This is a retrospective case series of patients with advanced TMD who were assessed and fit with customized PROSE lenses. Data were collected on PROSE fitting details including visual acuity (VA) before and after PROSE, slit-lamp findings, and corneal tomography scans.
Results:
Six eyes in four patients were included. All patients attempted at least one other contact lens (CL) modality before PROSE. Some patients had corneal comorbidities such as pseudopterygium and pseudobleb that contributed to intolerance to previous lenses and warranted extra considerations in the fitting process. With PROSE, VA improved in all six eyes. Patients with structural corneal comorbidities achieved improved vision, comfort, and lens tolerance with PROSE. Two eyes had noncorneal ocular comorbidities that limited PROSE efficacy. Another eye discontinued PROSE wear because of limbal stem-cell disease progression necessitating a limbal stem-cell transplant.
Conclusions:
PROSE treatment can be an effective option to improve vision and comfort for patients with advanced TMD who are intolerant to first-line therapeutic CL modalities, even in the presence of other corneal comorbidities.
